McKesson division achieves SCP technology standard
LIVONIA, Mich. — A consortium of companies that has developed standards to improve the quality and effectiveness of technology service operations has named McKesson Pharmacy Systems & Automation as making the grade, McKesson said.
The healthcare services company said it achieved the Service Capability and Performance standards, set by Service Strategies and several other technology companies.
"SCP certification is a tremendous achievement for our organization and attests to the unparalleled service, knowledge and professionalism of our customer support representatives," McKesson SVP Anan Khaldi said. "Because the SCP standards are universally recognized as a key benchmark for service excellence, it was imperative for us to go through the certification audit in order to improve our operational performance and enhance customer satisfaction."
McKesson said that in achieving the standers, it joined the ranks of more than 200 companies including Advent Software, Assurant Solutions, EMC, CompuCom Systems, Fuji Xerox, NetApp, Sophos and others.
Walgreens, Dollar General make InformationWeek’s list of top IT users
NEW YORK — A listing of the 500 most innovative users of information technology, as determined by industry magazine InformationWeek, includes the country’s largest retail pharmacy chain and a major dollar-store chain.
On the recently released InformationWeek 500, Walgreens ranked 89th, and Dollar General ranked in 98th place.
"This is great recognition for the work Walgreens has done to be at the forefront on innovative pharmacy, health-and-wellness solutions for communities across America," Walgreens chief information, innovation and improvement officer Tim Theriault said. "As health care and technology continue to evolve and influence consumer behavior, Walgreens will innovate and offer solutions to help people get, stay and life well."
InformationWeek tracks the technology, strategies, investments and administrative practices of companies across industries in compiling the list.
Report forecasts strong growth in Brazilian drug market despite coverage limitations
LONDON — The drug market in Brazil is expected to grow to nearly $60 billion by the next decade, but problems remain with coverage of the population, according to a new report.
The report, by research and consulting firm GlobalData, found that the Brazilian market would experience compounded annual growth of 12.7%, expanding from $12.4 billion in 2007 to $58.8 billion in 2020.
"The healthcare market in Brazil is primarily driven by an increase in disease burden, affordability and access to primary care," GlobalData director of healthcare industry dynamics Joshua Owide said. "However, health care does not cover the total population and therefore restricts further market growth."
The country’s healthcare system comprises two subsystems, a private one and a public one, and its private healthcare insurance system is the second-largest in the world, covering 23.7% of the population. The healthcare system also carries the highest tax burden in comparison with other sectors of the economy like education and finance. Required taxes to the service provider can reach 28%, including federal and state taxes.
"Brazilian hospitals still have inadequate resources and are therefore unable to provide access to healthcare provisions for every citizen, especially those in weaker economic sections," Owide said. "However, government initiatives, such as the increased availability of generic drugs through programs including the People’s Pharmacy, have contributed to the reduction of out-of-pocket expenditure and indirect price control, which stimulates competition from generics."